Latest news
Loading news…
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Cadent Therapeutics was acquired by Novartis in 2020 for $770M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cambridge, Massachusetts, United States
- Diversity spotlight
- Women Led
Acquisitions by Cadent Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Cadent Therapeutics
Chief Scientific Officer
3
professional contacts at Cadent Therapeutics
Contact execs at Cadent Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Cadent Therapeutics
Loading news…
FAQs about Cadent Therapeutics
People who checked this page also checked these
Sectors Cadent Therapeutics invests & acquires in
Browse the full Acquirezy directory.